Cargando…
LGMDD1 natural history and phenotypic spectrum: Implications for clinical trials
OBJECTIVE: To delineate the full phenotypic spectrum and characterize the natural history of limb girdle muscular dystrophy type D1 (LGMDD1). METHODS: We extracted age at clinical events of interest contributing to LGMDD1 disease burden via a systematic literature and chart review. Manual muscle tes...
Autores principales: | Findlay, Andrew R., Robinson, Sarah E., Poelker, Stephanie, Seiffert, Michelle, Bengoechea, Rocio, Weihl, Conrad C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930420/ https://www.ncbi.nlm.nih.gov/pubmed/36427278 http://dx.doi.org/10.1002/acn3.51709 |
Ejemplares similares
-
Phenotypic diversity in an international Cure VCP Disease registry
por: Ikenaga, Chiseko, et al.
Publicado: (2020) -
Lithium chloride corrects weakness and myopathology in a preclinical model of LGMD1D
por: Findlay, Andrew R., et al.
Publicado: (2019) -
Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection
por: Diez-Fuertes, Francisco, et al.
Publicado: (2022) -
DNAJB6 isoform specific knockdown: Therapeutic potential for limb girdle muscular dystrophy D1
por: Findlay, Andrew R., et al.
Publicado: (2023) -
Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease
por: Traschütz, Andreas, et al.
Publicado: (2021)